Chretien, Anne-Sophie <br/><br/>
Optimization of routine KRAS mutation PCR-based testing procedure for rational individualized first-line-targeted therapy selection in metastatic colorectal cancer.  [electronic resource] 

 -  Cancer medicine  Feb 2013 
 - 11-20 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2045-7634 
<br/><br/><label>Standard No.: </label>10.1002/cam4.47  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Colorectal Neoplasms--drug therapy<br/>DNA Mutational Analysis--methods<br/>DNA, Neoplasm--genetics<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Molecular Targeted Therapy<br/>Mutation<br/>Neoplasm Metastasis<br/>Nucleic Acid Denaturation<br/>Patient Selection<br/>Polymerase Chain Reaction--methods<br/>Polymorphism, Restriction Fragment Length<br/>Proto-Oncogene Proteins--genetics<br/>Proto-Oncogene Proteins p21(ras)<br/>Sensitivity and Specificity<br/>Young Adult<br/>ras Proteins--genetics